ACHE and Alzheimer disease: The four FDA-approved drugs for AD include three AChE inhibitors (donepezil, rivastigmine and galantamine), and memantine, a non-competitive N-methyl-ᴅ-aspartame (NMDA) glutamate receptor antagonist.